119 related articles for article (PubMed ID: 9639254)
1. The cholecystokinin-B receptor antagonist L-740,093 produces an insurmountable antagonism of CCK-4 stimulated functional response in cells expressing the human CCK-B receptor.
Dunlop J; Pass I; Ennis C
Neuropeptides; 1998 Apr; 32(2):157-60. PubMed ID: 9639254
[TBL] [Abstract][Full Text] [Related]
2. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl-1H-1,4- benzodiazepin-3-yl]-3-(3-methylphenyl)urea]: an irreversible cholecystokinin type-B receptor antagonist.
Dunlop J; Brammer N; Evans N; Ennis C
Biochem Pharmacol; 1997 Jul; 54(1):81-5. PubMed ID: 9296353
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of a Chinese hamster ovary cell line transfected with the human CCK-B receptor gene.
Dunlop J; Brammer N; Ennis C
Neuropeptides; 1996 Aug; 30(4):359-63. PubMed ID: 8914862
[TBL] [Abstract][Full Text] [Related]
4. Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.
Patel S; Smith AJ; Chapman KL; Fletcher AE; Kemp JA; Marshall GR; Hargreaves RJ; Ryecroft W; Iversen LL; Iversen SD
Mol Pharmacol; 1994 Nov; 46(5):943-8. PubMed ID: 7969084
[TBL] [Abstract][Full Text] [Related]
5. Role of N- and C-terminal substituents on the CCK-B agonist-antagonist pharmacological profile of Boc-Trp-Phg-Asp-Nal-NH2 derivatives.
Weng JH; Blommaert AG; Moizo L; Bado A; Ducos B; Böhme A; Garbay C; Roques BP
Bioorg Med Chem; 1996 Apr; 4(4):563-73. PubMed ID: 8735845
[TBL] [Abstract][Full Text] [Related]
6. Modification of receptor selectivity and functional activity in cholecystokinin peptoid ligands.
Dezube M; Sugg EE; Birkemo LS; Croom DK; Dougherty RW; Ervin GN; Grizzle MK; James MK; Johnson MF; Mosher JT
J Med Chem; 1995 Aug; 38(17):3384-90. PubMed ID: 7650691
[TBL] [Abstract][Full Text] [Related]
7. CCK receptor antagonists.
Dunlop J
Gen Pharmacol; 1998 Oct; 31(4):519-24. PubMed ID: 9792209
[TBL] [Abstract][Full Text] [Related]
8. Proliferative effects of cholecystokinin in GH3 pituitary cells mediated by CCK2 receptors and potentiated by insulin.
Smith AJ; McKernan RM
Br J Pharmacol; 1999 Jan; 126(1):79-86. PubMed ID: 10051123
[TBL] [Abstract][Full Text] [Related]
9. Role of cholecystokinin type B receptors in ultrasound induced behavior in rats.
Voits M; Beckett SR; Marsden CA; Fink H
Peptides; 1999; 20(3):383-6. PubMed ID: 10447098
[TBL] [Abstract][Full Text] [Related]
10. Full and partial agonist activity of C-terminal cholecystokinin peptides at the cloned human CCK-A receptor expressed in Chinese hamster ovary cells.
Dunlop J; Zhang Y; Evans N
Peptides; 1997; 18(6):865-8. PubMed ID: 9285936
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of both CCK-A and CCK-B receptors activates MAP kinases in AR42J and receptor-transfected CHO cells.
Dabrowski A; Detjen KM; Logsdon CD; Williams JA
Digestion; 1997; 58(4):361-7. PubMed ID: 9324163
[TBL] [Abstract][Full Text] [Related]
12. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin increases extracellular dopamine overflow in the anterior nucleus accumbens via CCK(B) receptors in the VTA assessed by in vivo voltammetry.
Reum T; Schäfer U; Marsden CA; Fink H; Morgenstern R
Neuropeptides; 1997 Feb; 31(1):82-8. PubMed ID: 9574843
[TBL] [Abstract][Full Text] [Related]
14. Effects of cholecystokinin peptides and GV 150013, a selective cholecystokininB receptor antagonist, on electrically evoked endogenous GABA release from rat cortical slices.
Ferraro L; Beani L; Trist D; Reggiani A; Bianchi C
J Neurochem; 1999 Nov; 73(5):1973-81. PubMed ID: 10537055
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning of an unusual bicistronic cholecystokinin receptor mRNA expressed in chicken brain: a structural and functional expression study.
Nilsson IB; Svensson SP; Monstein HJ
Regul Pept; 2003 Jun; 114(1):37-43. PubMed ID: 12763638
[TBL] [Abstract][Full Text] [Related]
16. The use of receptor desensitization to analyse CCKA and CCKB/gastrin receptors coupled to contraction in guinea-pig stomach muscle.
Bishop LA; Gerskowitch VP; Hull RA; Shankley NP; Black JW
Br J Pharmacol; 1995 Jan; 114(2):339-48. PubMed ID: 7881733
[TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin increases intracellular Ca2+ concentration in the Human JURKAT T Lymphocyte cell line.
Lignon MF; Bernad N; Martinez J
Eur J Pharmacol; 1993 May; 245(3):241-6. PubMed ID: 8335062
[TBL] [Abstract][Full Text] [Related]
18. Preferential blockade of cholecystokinin-8S-induced increases in aspartate and glutamate levels by the CCK(B) receptor antagonist, L-365,260, in rat brain.
Ge J; Long SK; Kilpatrick IC
Eur J Pharmacol; 1998 Mar; 345(2):163-70. PubMed ID: 9600632
[TBL] [Abstract][Full Text] [Related]
19. Influence of L-365,260, a CCK-B/gastrin receptor antagonist, on tetragastrin-stimulated mucin metabolism in rat gastric mucosa.
Komuro Y; Ichikawa T; Ishihara K; Saigenji K; Hotta K
Pharmacology; 1999 Jul; 59(1):11-20. PubMed ID: 10352422
[TBL] [Abstract][Full Text] [Related]
20. Central and peripheral cholecystokinin receptors in chickens differ from those in mammals.
Rodríguez-Sinovas A; Fernández AG; Goñalons E
Regul Pept; 1995 Dec; 60(1):47-54. PubMed ID: 8747783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
